XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income (Loss)
Balance beginning of period (in shares) at Dec. 31, 2019   72,133,163      
Balance beginning of period at Dec. 31, 2019 $ 1,819,601 $ 72 $ 5,569,356 $ (3,750,884) $ 1,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (10,174)     (10,174)  
  Unrealized gain (loss) on derivatives (16,199)       (16,199)
Reclassification to interest expense, net 2,634       2,634
Reclassification to equity in earnings of unconsolidated entities 59       59
Distributions declared (54,604)     (54,604)  
Stock-based compensation, net (in shares)   71,199      
Stock-based compensation, net 2,840   2,840    
Repurchase of common stock under share repurchase plan (in shares)   (213,612)      
Common stock issuance costs in excess of proceeds from distribution reinvestment plan (5,201)   (5,201)    
Common stock issuance costs in excess of proceeds from distribution reinvestment plan (in shares)   7,904      
Common stock issuance costs in excess of proceeds from distribution reinvestment plan (93)   (93)    
Balance end of period (in shares) at Dec. 31, 2020   71,998,654      
Balance end of period at Dec. 31, 2020 1,738,863 $ 72 5,566,902 (3,815,662) (12,449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (5,360)     (5,360)  
  Unrealized gain (loss) on derivatives 3,795       3,795
Reclassification to interest expense, net 4,198       4,198
Reclassification to equity in earnings of unconsolidated entities 134       134
Distributions declared (55,721)     (55,721)  
Stock-based compensation, net (in shares)   101,363      
Stock-based compensation, net 5,659 $ 6 5,653    
Repurchase of common stock under share repurchase plan (in shares)   (755,643)      
Common stock issuance costs in excess of proceeds from distribution reinvestment plan (16,685) $ (7) (16,678)    
Repurchase of common stock through tender offer (in shares)   (4,000,000)      
Repurchase of common stock through tender offer (103,331) $ (4) (103,327)    
Balance end of period (in shares) at Dec. 31, 2021   67,344,374      
Balance end of period at Dec. 31, 2021 1,571,552 $ 67 5,452,550 (3,876,743) (4,322)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 52,233     52,233  
  Unrealized gain (loss) on derivatives 32,052       32,052
Reclassification to interest expense, net (405)       (405)
Reclassification to equity in earnings of unconsolidated entities (604)       (604)
Distributions declared (55,337)     (55,337)  
Stock-based compensation, net (in shares)   128,179      
Stock-based compensation, net 4,418   4,418    
Balance end of period (in shares) at Dec. 31, 2022   67,472,553      
Balance end of period at Dec. 31, 2022 $ 1,603,909 $ 67 $ 5,456,968 $ (3,879,847) $ 26,721